Oric Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Oric Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Oric Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Oric Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $6.0M | 652k | 9.20 |
| 2023-09-30 | $274k | 45k | 6.07 |
| 2023-06-30 | $490k | 63k | 7.76 |
| 2023-03-31 | $338k | 59k | 5.70 |
| 2022-12-31 | $350k | 59k | 5.89 |
| 2022-03-31 | $340k | 64k | 5.34 |
| 2021-12-31 | $702k | 48k | 14.70 |